REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Regulatory News (HAYD)

Share Price Information for Haydale (HAYD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.46
Bid: 0.45
Ask: 0.47
Change: 0.00 (0.00%)
Spread: 0.02 (4.444%)
Open: 0.46
High: 0.46
Low: 0.46
Prev. Close: 0.46
HAYD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Launch of Taiwan operations

9 Aug 2017 07:00

RNS Number : 4483N
Haydale Graphene Industries PLC
09 August 2017
 

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

 

For immediate release

9 August 2017

 

Haydale Graphene Industries plc

 

('Haydale' or the 'Group')

 

Launch of Taiwan operations

 

Haydale (AIM:HAYD), the global advanced materials group, is pleased to announce the launch of its Taiwan operations, Haydale Technologies (Taiwan) Co., Ltd., ('HTW'), which will operate as a dedicated producer and sales outlet of graphene-based conductive inks and pastes, including other functional and specialty inks and pastes.

 

Located in Kaohsiung, Southern Taiwan, HTW has largely completed the set-up of its own dedicated ink production facility to meet its anticipated demand. Haydale has been working in Taiwan for more than 18 months, having determined in late 2015 that the region's focus on functional inks and pastes could provide an important route to market for Haydale's tailored graphene-based materials. The work involved market assessments, in-country technical capability, ability to gain regulatory approvals and gaining a deep understanding of the targeted print customers' needs.

 

Haydale's proprietary graphene-based pastes have been developed in the Far East focussed on the Self-Monitoring Blood Glucose ('SMBG') device market. To date Haydale's inks have been incorporated into test products with several Taiwan-based printing customers who have been progressing regulatory approval for sales of their diagnostic products incorporating Haydale inks into the US and EU markets. Although Haydale has no current visibility on order quantities, the Group anticipates that sales of its tailored graphene-based paste to these customers will commence during the 2017 calendar year.

 

Traditionally, highly conductive inks and pastes have been dominated by metal-based inks incorporating silver and copper. Whilst graphene is not expected to completely replace the conductive properties of silver-based inks, provided it meets acceptable printer specifications, graphene offers many advantages such as recyclability, lower unit costs and the fact that the material is not susceptible to volatile market price movements.

A key reason for Haydale targeting the SMBG sector opportunity is that, according to market research firm Research & Markets, the SMBG device market is expected to grow to over US$16 billion by 2020 as the incidence of diabetes is increasing dramatically, with more than 640 million sufferers estimated worldwide by 20401.

 

Commenting on the opening of HTW, Ray Gibbs, CEO of Haydale, said:

"The development of our graphene-based inks has been focused on the screen printing market for over three years, which started with Haydale being awarded an Innovate UK grant for the production of ink for the self-monitoring blood glucose device market. Three years later we have expectations on securing sales this calendar year and the necessary FDA and regulatory approvals through dedicated printers such that we were confident to open a operation facility in Taiwan to service our collaboration partners' needs. The biomedical sensor market is massive and we consider that the Far East has a significant portion of this growing sector. I look forward to making more announcements on progress in ink sales over the coming months."

 

 

1. (Source:https://www.researchandmarkets.com/research/vhwlsj/blood_glucose).

 

- Ends -

 

For further information:

Haydale Graphene Industries plc

 

Ray Gibbs, Chief Executive Officer

Tel: +44 (0) 1269 842 946

Matt Wood, Finance Director

www.haydale.com

Trevor Phillips, Head of Communications

 

 

 

Cairn Financial Advisers LLP (Nominated Adviser)

 

Tony Rawlinson / Emma Earl

Tel: +44 (0) 20 7213 0880

 

 

 

Cantor Fitzgerald Europe (Broker)

 

David Foreman / Will Goode (Corporate Finance)

Tel: +44 (0) 20 7894 7000

Mark Westcott / Alex Pollen (Sales)

 

 

Media enquiries:

Buchanan

 

Henry Harrison-Topham / Jamie Hooper

Tel: +44 (0) 20 7466 5000

haydale@buchanan.uk.com

www.buchanan.uk.com

 

Notes to Editors

Haydale is a global technologies and advanced materials group that facilitates the integration of nanomaterials into the next generation of commercial technologies and industrial materials. With expertise in graphene, silicon carbide and other nanomaterials, Haydale is able to deliver improvements in electrical, thermal and mechanical properties, as well as toughness. Haydale has granted patents for its technologies in Europe, USA, Japan, Australia and China and operates from six facilities in the UK, USA and the Far East.

 

For more information please visit: www.haydale.com

Twitter: @haydalegraphene

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKMGGRKRVGNZM
Date   Source Headline
22nd Feb 201911:00 amRNSPrice Monitoring Extension
22nd Feb 20197:01 amRNSProposed Placing and Open Offer
22nd Feb 20197:00 amRNSInterim Results
20th Feb 20192:06 pmRNSSecond Price Monitoring Extn
20th Feb 20192:00 pmRNSPrice Monitoring Extension
20th Feb 20199:00 amRNSPrice Monitoring Extension
20th Feb 20197:00 amRNSComment on Speculation
21st Jan 20197:00 amRNSHolding(s) in Company
15th Jan 20197:21 amRNSAgreement for Functionalised Piezoresistive Ink
14th Jan 20197:00 amRNSHolding(s) in Company
14th Jan 20197:00 amRNSDirector/PDMR Shareholding
7th Jan 20194:15 pmRNSFurther re Issue of Equity
4th Jan 201911:51 amRNSDirector/PDMR Shareholding
28th Dec 20187:00 amRNSPDMR Shareholding
21st Dec 201812:22 pmRNSResult of AGM
21st Dec 20187:00 amRNSFinance facility, issue of equity, director change
30th Nov 20184:35 pmRNSPrice Monitoring Extension
29th Nov 20187:00 amRNSUpdate on functionalised graphene ink sales
29th Nov 20187:00 amRNSAnnual Report & Notice of AGM
27th Nov 20189:31 amRNSGEIC to join Haydale and Wheelsure collaboration
27th Nov 20189:05 amRNSSecond Price Monitoring Extn
27th Nov 20189:00 amRNSPrice Monitoring Extension
26th Nov 20184:40 pmRNSSecond Price Monitoring Extn
26th Nov 20184:35 pmRNSPrice Monitoring Extension
19th Nov 20187:00 amRNSLicense agreement for anti-counterfeiting product
13th Nov 20187:00 amRNSJoint Development Agreement with Star RFID
12th Nov 201812:40 pmEQSHardman & Co Research: Haydale (HAYD): Enlightenment delayed
9th Nov 20187:00 amRNSFinancing Update
12th Oct 20187:00 amRNSDevelopment funding from Niche Vehicle Network
28th Sep 20182:54 pmRNSDirector Dealing
27th Sep 20189:29 amRNSNOTIFICATION OF MAJOR HOLDINGS
26th Sep 20185:21 pmEQSHardman & Co Research: Haydale (HAYD): Exuberance, reality; enlightenment now to follow
18th Sep 20187:00 amRNSDevelopment Contract with the EIS
18th Sep 20187:00 amRNSFull Year Results
11th Sep 20187:00 amRNSContract Updates & Notice of Results
5th Sep 20187:00 amRNSBoard Changes
13th Aug 20187:00 amRNSDirector Dealing
8th Aug 20183:01 pmRNSNotification of Major Holdings
8th Aug 201811:00 amRNSPrice Monitoring Extension
7th Aug 201810:24 amRNSNOTIFICATION OF MAJOR HOLDINGS
1st Aug 20187:00 amRNSWorld's First Graphene Skinned Plane
18th Jul 20187:00 amRNSNPL & NGI launch graphene characterisation service
13th Jul 20182:05 pmRNSSecond Price Monitoring Extn
13th Jul 20182:00 pmRNSPrice Monitoring Extension
25th Jun 20187:00 amRNSPartnership with GEIC
22nd Jun 20184:20 pmRNSNotification of Major Holdings
20th Jun 20182:52 pmRNSDirector Dealing
19th Jun 20187:00 amRNSStrong Commercial Progress
18th Jun 20187:00 amRNSNotification of Major Holdings
13th Jun 20189:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.